All Topics

• Caraco Digoxin Tablets Recalled for Potential Health Risks

  Scott Kappes | April 01, 2009 6:35 PM | 0 CommentsHouston, TX

  Generic pharmaceutical maker Caraco Pharmacuetical Labratories has announced a nationwide recall of Caraco brand Digoxin tablets for possible overdose risks. The recall includes all Caraco brand...

• Artificial Turf Cited For Lead Risks

  Scott Kappes | June 26, 2008 1:53 PM | 0 CommentsHouston, TX

  Lead seems to be showing up everywhere in recent months. We have seen excessive amounts of lead in everything from charms and pendants to toys and clothing. Now artificial turf used on all types of...

• Iraq Vets With PTSD Used as Chantix Guinea Pigs

  Scott Kappes | June 17, 2008 5:48 PM | 1 CommentHouston, TX

  Today the Washington Times and ABC News are reporting that soldiers returning from Iraq are being used as test patients for medications that have been linked to serious adverse reactions....

• Virginia Hospitals Admit Implanting Defective Kugel Mesh Patch in Seven Patients

  Scott Kappes | June 06, 2008 1:18 PM | 0 CommentsHouston, TX

  A Virginia Hospital system, Sentara, admitted this week that they implanted seven patients with the defective Kugel Mesh Hernia Patch after the FDA issued a Class I recall for the defective...

• Bayer Pulls Remaining Stocks of Trasylol

  Scott Kappes | May 15, 2008 12:25 PM | 0 CommentsHouston, TX

  Yesterday the FDA announced that Bayer would be removing remaining stocks of Trasylol after a study confirming suspected increased death risks was published in the New England Journal of...

• Hepatitis Scare Prompts State Wide Inspection

  Scott Kappes | March 10, 2008 1:54 PM | 0 CommentsHouston, TX

  Over the weekend the Las Vegas Sun reported that a local clinic might have exposed up to 40,000 patients to a risk of hepatitis and HIV. The Endoscopy Center of Southern Nevada should have been inspected by state health organizations every three years, but had not been inspected over seven years. In order to lower costs that clinic allegedly reused syringes and vials and skimped on virtually...

• Luby's Hit With Lawsuit Over Parking Lot Injury

  Scott Kappes | January 18, 2008 12:13 PM | 0 CommentsHouston, TX

  On January 15 Kathy Addison of Port Arthur, TX filed a personal injury lawsuit claiming that a defect in the Luby's parking lot caused her to trip and consequently injure her elbow. The lawsuit alleges that Luby's Inc. was negligent in failing to maintain a safe premises. The suit claims that the parking lot posed an unreasonable risk and the obvious defect should have been repaired to create a...

• Family of Man Killed in Bus Accident Sues Company, Driver

  Jenny Albano | January 16, 2008 4:17 PM | 0 CommentsHouston, TX

  The family of a man who was killed in a recent bus crash near Victoria is suing the bus owner, the operator and the driver of the vehicle. Pedro Mendez was killed during the accident that occurred on January 2 that seriously injured many other passengers. The bus was headed to Houston from Monterrey, Mexico.The lawsuit, filed Tuesday in Harris County District Court, alleges three companies...

• Truck and Tour Bus Collide, Killing One and Injuring Many Others

  Jenny Albano | January 02, 2008 8:06 PM | 0 CommentsHouston, TX

  A Mexican tour bus collided with a truck on Wednesday, January 2, killing one and injuring several others. The charter bus, carrying almost 50 passengers, veered off the highway and then over-corrected, which caused the bus to tip over onto its side. Then, once the bus had crashed on U.S. 59 near Victoria, a pickup truck collided with the overturned bus. The driver of the pickup was not...

• FDA Issues Safety Alert on Avandia

  Vickye Young | June 01, 2007 4:03 PM | 0 CommentsHouston, TX

  On May 21, 2007,the FDA issued a safety alert about Avandia (rosiglitazone maleate) after a study in the New England Journal of Medicine linked the popular diabetes drug to a 43% increase in the risk of heart attack and a 64% increase in the risk of death from all cardiovascular causes. Avandia has become a blockbuster drug for GlaxoSmithKline; since Avandia's launch, over 6 million Americans...